Trial Profile
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty, a Prospective, Double Blind, Phase III Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Surgical blood loss
- Focus Therapeutic Use
- 14 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Nov 2010 New trial record